Responding to Government plans to cut up to 10% on revenues from patents developed in the UK, pharmaceutical giant GlaxoSmithKline (GSK) has announced the creation of 1,000 jobs in the country.
Around 60% of the jobs will be created in the biopharmaceutical sector, with the remaining 400 in other sectors of the company, GSK said.
Around ??500 million of additional investment will also be made for these jobs, the company added.
No details have been confirmed regarding when the vacancies will be opened.
In a bid to attract more high-technology companies such as the pharmaceutical and biotechnology industries into Britain, Chancellor Alistair Darling revealed plans for the "patent box" in December.
According to the scheme, the UK patent income will be charged a special corporation tax rate, different from the usual rate of 28%, from April 2013.
The patent box aims to encourage more businesses working in intellectual property and innovation fields to make the UK their base and to stop those who are already established in the country from moving out over the tax regime.
Countries like Switzerland, the Netherlands and Belgium already have such schemes in place to boost their life industries sector.
